نتایج جستجو برای: pkd1

تعداد نتایج: 895  

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2015
Shinya Ohata Vicente Herranz-Pérez Jin Nakatani Alessandra Boletta José Manuel García-Verdugo Arturo Álvarez-Buylla

UNLABELLED Directional beating of ependymal (E) cells' cilia in the walls of the ventricles in the brain is essential for proper CSF flow. E cells display two forms of planar cell polarity (PCP): rotational polarity of individual cilium and translational polarity (asymmetric positioning of cilia in the apical area). The orientation of individual E cells varies according to their location in the...

Journal: :Neuroscience Research 2015
Erda Avriyanti Nur Atik Masataka Kunii Naomi Furumoto Tomohiko Iwano Shin-ichiro Yoshimura Reiko Harada Akihiro Harada

Mammalian protein kinase D (PKD) isoforms have been proposed to regulate diverse biological processes, including the establishment and maintenance of neuronal polarity. To investigate the function of PKD in neuronal polarization in vivo, we generated PKD knockout (KO) mice. Here, we show that the brain, particularly the hippocampus, of both PKD1 KO and PKD2 KO mice was similar to that of contro...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
Jens Fielitz Mi-Sung Kim John M Shelton Xiaoxia Qi Joseph A Hill James A Richardson Rhonda Bassel-Duby Eric N Olson

The adult heart responds to biomechanical stress and neurohormonal signaling by hypertrophic growth, accompanied by fibrosis, diminished pump function, and activation of a fetal gene program. Class II histone deacetylases (HDACs) suppress stress-dependent remodeling of the heart via their association with the MEF2 transcription factor, an activator of heart disease. Protein kinase D (PKD) is a ...

Journal: :international journal of molecular and cellular medicine 0
javad jamshidi noncommunicable diseases research center, fasa university of medical sciences, fasa, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی فسا (fasa university of medical sciences) hamed naderi department of neurology, school of medicine, imam khomeini hospital and iranian center of neurological research, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences) shaghayegh taghavi department of medical genetics, school of medicine, shahid beheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) babak emamalizadeh department of medical genetics, school of medicine, shahid beheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) hossein darvish department of medical genetics, school of medicine, shahid beheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences)

Journal: :Pharmacophore 2022

Autosomal dominant polycystic kidney disease (ADPKD) is caused by a mutation in the disease1 (PKD1) gene, which responsible for 85% of ADPKD cases. The PKD1 gene encodes polycystin-1 (PC1) protein that has large extracellular area containing many polypeptide motifs. region PC1 includes several well-defined peptide domains show it been involved cell-cell and/or cell-matrix interactions. One regi...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010
Stephanie J Leuenroth Natasha Bencivenga Halima Chahboune Fahmeed Hyder Craig M Crews

BACKGROUND Autosomal dominant polycystic kidney disease (ADPKD), a major cause of end-stage renal failure, results from genetic mutation of either polycystin-1 (Pkd1) or polycystin-2 (Pkd2). In order to develop novel therapies to treat the advancement of disease progression, numerous rodent models of different genetic backgrounds are available to study cyst development. METHODS Here, a Pkd1-f...

Journal: :American journal of physiology. Renal physiology 2008
M Rafiq Islam Sanjeev Puri Marianna Rodova Brenda S Magenheimer Robin L Maser James P Calvet

The retinoic acids all-trans retinoic acid (AT-RA) and 9-cis retinoic acid (9C-RA) and the retinoic acid receptors RAR and RXR significantly induce transcriptional activity from a 200-bp PKD1 proximal promoter in transfected mammalian cells. This PKD1 promoter region contains Ets, p53, and GC box motifs, but lacks a canonical RAR/RXR motif. Mutagenesis of the Ets sites did not affect RA inducti...

2015
Hamad Ali Naser Hussain Medhat Naim Mohamed Zayed Fahd Al-Mulla Elijah O Kehinde Lauren M Seaburg Jamie L Sundsbak Peter C Harris

BACKGROUND Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common form of Polycystic Kidney Disease (PKD) and occurs at a frequency of 1/800 to 1/1000 affecting all ethnic groups worldwide. ADPKD shows significant intrafamilial phenotypic variability in the rate of disease progression and extra-renal manifestations, which suggests the involvement of heritable modifier genes. He...

2014
Binu M. Paul Mark B. Consugar Moonnoh Ryan Lee Jamie L. Sundsbak Christina M. Heyer Sandro Rossetti Vickie J. Kubly Katharina Hopp Vicente E. Torres Eliecer Coto Maurizio Clementi Nadja Bogdanova Edgar de Almeida Daniel G. Bichet Peter C. Harris

Mutations to PKD1 and PKD2 are associated with autosomal dominant polycystic kidney disease (ADPKD). The absence of apparent PKD1/PKD2 linkage in five published European or North American families with ADPKD suggested a third locus, designated PKD3. Here we re-evaluated these families by updating clinical information, re-sampling where possible, and mutation screening for PKD1/PKD2. In the Fren...

2016
Kelly A. Rogers Sarah E. Moreno Laurie A. Smith Hervé Husson Nikolay O. Bukanov Steven R. Ledbetter Yeva Budman Yuefeng Lu Bing Wang Oxana Ibraghimov‐Beskrovnaya Thomas A. Natoli

Development of a disease-modifying therapy to treat autosomal dominant polycystic kidney disease (ADPKD) requires well-characterized preclinical models that accurately reflect the pathology and biochemical changes associated with the disease. Using a Pkd1 conditional knockout mouse, we demonstrate that subtly altering the timing and extent of Pkd1 deletion can have a significant impact on the o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید